JP2018537100A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018537100A5 JP2018537100A5 JP2018529050A JP2018529050A JP2018537100A5 JP 2018537100 A5 JP2018537100 A5 JP 2018537100A5 JP 2018529050 A JP2018529050 A JP 2018529050A JP 2018529050 A JP2018529050 A JP 2018529050A JP 2018537100 A5 JP2018537100 A5 JP 2018537100A5
- Authority
- JP
- Japan
- Prior art keywords
- target molecule
- level
- expression
- tnf therapy
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1521357.2 | 2015-12-03 | ||
| GBGB1521357.2A GB201521357D0 (en) | 2015-12-03 | 2015-12-03 | Methods for predicting response to anti-TNF therapy |
| PCT/GB2016/053798 WO2017093750A1 (en) | 2015-12-03 | 2016-12-02 | Methods for predicting response to anti-tnf therapy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018537100A JP2018537100A (ja) | 2018-12-20 |
| JP2018537100A5 true JP2018537100A5 (enExample) | 2020-01-16 |
Family
ID=55234362
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018529050A Pending JP2018537100A (ja) | 2015-12-03 | 2016-12-02 | 抗ｔｎｆ療法に対する応答を予測する方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20190367984A1 (enExample) |
| EP (1) | EP3384044A1 (enExample) |
| JP (1) | JP2018537100A (enExample) |
| CN (1) | CN108291261A (enExample) |
| AU (1) | AU2016364003A1 (enExample) |
| CA (1) | CA3005695A1 (enExample) |
| GB (1) | GB201521357D0 (enExample) |
| WO (1) | WO2017093750A1 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2018113694A (ru) | 2015-09-17 | 2019-10-17 | Эмджен Инк. | Прогноз клинического ответа на антагонисты ил-23 с использованием биомаркеров сигнального пути ил-23 |
| EP3654993A4 (en) * | 2017-07-17 | 2021-08-25 | The Broad Institute, Inc. | CELL ATLAS OF HEALTHY HUMAN COLUMN AND HUMAN COLUMN WITH COLITIS ULCEROSA |
| CN108047327B (zh) * | 2017-11-29 | 2020-08-07 | 中国医学科学院北京协和医院 | 一种检测骨关节炎的生物标志物及其应用 |
| WO2019159186A1 (en) * | 2018-02-19 | 2019-08-22 | Genefron Ltd. | Methods of determining response to tnf alpha blockers |
| EP3765634A4 (en) | 2018-03-16 | 2021-12-01 | Scipher Medicine Corporation | METHODS AND SYSTEMS FOR PREDICTING THE RESPONSE TO ANTI-TNF THERAPIES |
| SG11202104882WA (en) * | 2018-11-15 | 2021-06-29 | Ampel Biosolutions Llc | Machine learning disease prediction and treatment prioritization |
| JP2022541125A (ja) | 2019-06-27 | 2022-09-22 | サイファー メディシン コーポレーション | 患者を層別化するための分類子の開発 |
| CA3152279A1 (en) * | 2019-10-04 | 2021-04-08 | The Regents Of The University Of Michigan | Methods for determining responsiveness to anti-tumor necrosis factor therapy in the treatment of psoriasis |
| CA3199737A1 (en) * | 2020-11-30 | 2022-06-02 | Tobin Dickerson | Microneedle devices and methods, and skin condition assays |
| US20220291238A1 (en) * | 2021-03-12 | 2022-09-15 | Janssen Biotech, Inc. | Methods for Predicting Treatment Response in Ulcerative Colitis |
| CN113373218A (zh) * | 2021-08-04 | 2021-09-10 | 杭州浙大迪迅生物基因工程有限公司 | 一组检测人嗜酸性粒细胞阳离子蛋白mRNA表达的引物组和试剂盒 |
| CN116559453A (zh) * | 2022-11-22 | 2023-08-08 | 杭州广科安德生物科技有限公司 | 一种用于肺癌检测的生物标志物 |
| WO2026047197A1 (en) * | 2024-08-30 | 2026-03-05 | Sanofi Biotechnology | Differential biomarkers for anti-interleukin-6 and anti-tumor necrosis factor-α treatment response in rheumatoid arthritis |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2658171A1 (en) * | 2006-07-13 | 2008-01-17 | Source Precision Medicine, Inc. D/B/A Source Mdx | Gene expression profiling for identification, monitoring and treatment of multiple sclerosis |
| WO2008132176A2 (en) * | 2007-04-27 | 2008-11-06 | Universite Catholique De Louvain | Method for evaluating the response of an individual to tnf blocking therapy |
| BRPI0812461A2 (pt) * | 2007-06-08 | 2017-06-13 | Biogen Idec Inc | método de prever a resposta de um indivíduo a uma terapia, método de tratamento de um distúrbio imunológico, composição e kit |
| EP2192197A1 (en) * | 2008-11-27 | 2010-06-02 | Vereniging voor christelijk hoger onderwijs, wetenschappelijk onderzoek en patiëntenzorg | Predicting clinical response to treatment with a soluble tnf-antagonist or tnf, or a tnf receptor agonist |
| CN102597268B (zh) * | 2009-09-03 | 2017-09-22 | 弗·哈夫曼-拉罗切有限公司 | 用于治疗、诊断和监控类风湿性关节炎的方法 |
| US20130042333A1 (en) * | 2011-05-06 | 2013-02-14 | Jean-Gabriel JUDDE | Markers for cancer prognosis and therapy and methods of use |
| HU230680B1 (hu) * | 2012-10-19 | 2017-08-28 | Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag | Diagnosztikai eljárás |
| US9809854B2 (en) * | 2012-11-15 | 2017-11-07 | New York Society For The Ruptured And Crippled Maintaining The Hospital For Special Surgery | Biomarkers for disease activity and clinical manifestations systemic lupus erythematosus |
-
2015
- 2015-12-03 GB GBGB1521357.2A patent/GB201521357D0/en not_active Ceased
-
2016
- 2016-12-02 EP EP16808777.3A patent/EP3384044A1/en not_active Withdrawn
- 2016-12-02 US US15/780,762 patent/US20190367984A1/en not_active Abandoned
- 2016-12-02 CN CN201680071029.6A patent/CN108291261A/zh active Pending
- 2016-12-02 CA CA3005695A patent/CA3005695A1/en not_active Abandoned
- 2016-12-02 AU AU2016364003A patent/AU2016364003A1/en not_active Abandoned
- 2016-12-02 JP JP2018529050A patent/JP2018537100A/ja active Pending
- 2016-12-02 WO PCT/GB2016/053798 patent/WO2017093750A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018537100A5 (enExample) | ||
| Yao et al. | Development of potential pharmacodynamic and diagnostic markers for anti-IFN-α monoclonal antibody trials in systemic lupus erythematosus | |
| Tan et al. | Emerging molecular markers towards potential diagnostic panels for lupus | |
| Goronzy et al. | Prognostic markers of radiographic progression in early rheumatoid arthritis | |
| JP5675829B2 (ja) | 炎症性疾患活動性を測定およびモニタリングするためのバイオマーカーおよび方法 | |
| Li et al. | Interferon signature gene expression is correlated with autoantibody profiles in patients with incomplete lupus syndromes | |
| Paradowska‐Gorycka et al. | Association between IL‐17F gene polymorphisms and susceptibility to and severity of rheumatoid arthritis (RA) | |
| Hardt et al. | Integrated single cell and spatial transcriptomics reveal autoreactive differentiated B cells in joints of early rheumatoid arthritis | |
| CN105164536B (zh) | 阿尔兹海默症诊断的组合物和方法 | |
| Orsini et al. | Design and MinION testing of a nanopore targeted gene sequencing panel for chronic lymphocytic leukemia | |
| Mesko et al. | Peripheral blood derived gene panels predict response to infliximab in rheumatoid arthritis and Crohn's disease | |
| US20260063632A1 (en) | Biomarkers For A Systemic Lupus Erythematosus (SLE) Disease Activity Immune Index That Characterizes Disease Activity | |
| CA3005695A1 (en) | Methods for predicting response to anti-tnf therapy | |
| Andreu-Sánchez et al. | Phage display sequencing reveals that genetic, environmental, and intrinsic factors influence variation of human antibody epitope repertoire | |
| RU2016144177A (ru) | Способы избирательного лечения астмы с использованием антагонистов il-13 | |
| EP3884276A2 (en) | Predicting a treatment response in inflammatory bowel disease | |
| Fattah et al. | The expression of zinc finger 804a (ZNF804a) and cyclin-dependent kinase 1 (CDK1) genes is related to the pathogenesis of rheumatoid arthritis | |
| Walczak et al. | Long-range PCR libraries and next-generation sequencing for pharmacogenetic studies of patients treated with anti-TNF drugs | |
| Simmonds et al. | The search for the genetic contribution to autoimmune thyroid disease: the never ending story? | |
| US8580528B2 (en) | Method for prognosticating the clinical response of a patient to B-lymphocyte inhibiting or depleting therapy | |
| Surmiak et al. | Expression profile of proinflammatory genes in neutrophil-enriched granulocytes stimulated with native anti-PR3 autoantibodies | |
| Zhang et al. | PRDX6 AS1 gene polymorphisms and SLE susceptibility in Chinese populations | |
| Marquez et al. | Emerging aspects of molecular biomarkers for diagnosis, prognosis and treatment response in rheumatoid arthritis | |
| KR102155306B1 (ko) | 고밀도지질단백질콜레스테롤 수준을 예측하기 위한 조성물, 키트, 및 이를 이용한 방법 | |
| Al-Garawi et al. | Shifting of immune responsiveness to house dust mite by influenza A infection: genomic insights |